Designed to detect over 90 types of mycoplasma! Testing using real-time PCR method.
Our company offers "Mycoplasma Detection Testing." Due to its size, mycoplasma can pass through sterilizing filters, and many antibiotics are ineffective against it, making it easy to contaminate cell culture media. Additionally, even when it contaminates and proliferates in cell culture media, it is difficult to detect visually, necessitating special management. We conduct mycoplasma detection testing using a real-time PCR method designed to detect over 90 types of mycoplasma. We also offer testing to confirm the suitability of measurements by adding a known quantity of mycoplasma DNA to the sample. [Features] - Mycoplasma can pass through sterilizing filters due to its size. - It is easy to contaminate cell culture media because it is resistant to antibiotics. - Special management is required because it is difficult to visually detect even when it contaminates and proliferates in cell culture media. - Real-time PCR method designed to detect over 90 types of mycoplasma. - We also conduct tests to confirm measurement suitability by adding a known quantity of mycoplasma DNA to the sample. *For more details, please refer to the related links or feel free to contact us.*
Inquire About This Product
basic information
【Other Contract Quality Tests】 ■ Sterility Test ■ Endotoxin Test ■ Other Quality Tests *For more details, please refer to the related links or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
【Purpose】 ■Mycoplasma Negativity Test *For more details, please refer to the related links or feel free to contact us.
Company information
BioMedica Solutions Co., Ltd. is a company formed through collaboration between Panasonic Healthcare Co., Ltd. (formerly Sanyo Electric Co., Ltd. BioMedica Division), a top manufacturer of cell culture processing facilities and equipment, and Terra Co., Ltd., which possesses cell culture technology, know-how, and the largest track record of human cell culture in Japan. We aim to provide the latest cell culture technology and management know-how, contributing to the realization of regenerative medicine and cell therapy, and striving for a society where many people can safely receive cell therapy.